Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  ALK-FAK inhibitor CEP-37440
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
To Determine the Maximum Tolerated Dose of Oral CEP-37440 in Patients With Advanced or Metastatic Solid Tumors
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: C37440/1108, NCI-2013-02456, NCT01922752
Start Over